Inflammation in atherothrombotic disease.
Atherosclerosis is a systemic disease in which vascular inflammation plays a key role. Indeed, inflammation is closely linked to atherosclerotic disease at all stages, from silent progression to clinical manifestations. There is now strong epidemiologic evidence that mediators of inflammation, like C-reactive protein, predict cardiovascular risk independently of "classical" risk factors. Consequently, new disease-modifying drugs targeting inflammation are under investigation and may change the approach to treatment of atherosclerosis in the near future.